| 三阳性乳腺癌的治疗进展 |
| |
| 引用本文： | 张国泰,' target='_blank'>,符德元.三阳性乳腺癌的治疗进展[J].现代肿瘤医学,2020,0(4):687-690. |
| |
| 作者姓名： | 张国泰 ' target='_blank'> 符德元 |
| |
| 作者单位： | 1.大连医科大学，辽宁 大连 116044;2.苏北人民医院甲乳外科，江苏 扬州 225001 |
| |
| 摘 要： | 三阳性乳腺癌(triple-positive breast cancer,TPBC)是乳腺癌分子分型中特殊的一类，以ER/PR/HER-2均阳性表达为特征，对化疗、靶向治疗、内分泌治疗都具有敏感性。虽然理论上联合治疗可能使患者获得更好的治疗效果，但是TPBC的治疗没有得到期望的预后。因此探索其临床特征、耐药机制及针对性治疗是今后的发展方向。
|
| 关 键 词： | 三阳性 乳腺癌 治疗 |
The advance of treatment in triple-positive breast cancer |
| |
| Zhang Guotai,' target='_blank'>,Fu Deyuan.The advance of treatment in triple-positive breast cancer[J].Journal of Modern Oncology,2020,0(4):687-690. |
| |
| Authors: | Zhang Guotai ' target='_blank'> Fu Deyuan |
| |
| Affiliation: | 1.Dalian Medical University,Liaoning Dalian 116044,China;2.Department of Thyroid and Breast Surgery,Northern Jiangsu People's Hospital,Jiangsu Yangzhou 225001,China. |
| |
| Abstract: | Triple-positive breast cancer is one of the special molecular subtype of breast cancer,characterized by the expression of ER,PR,HER-2,sensitive to chemotherapy,targeted therapy,endocrine therapy.Theoretically,combination therapy for its effect would be more effective,however,the treatment of TPBC did not achieve the desired prognosis.The future research should focus on the exploration of characteristics,resistance mechanism and targeted therapy. |
| |
| Keywords: | triple-positive breast cancer therapy |
|
| 点击此处可从《现代肿瘤医学》浏览原始摘要信息 |
|
点击此处可从《现代肿瘤医学》下载全文 |
|
